GLP-3RT
Same-day shipping — Ships next business day, cutoff 3 PM ET.
≥99% purity verified by independent HPLC and mass spectrometry (MS) through Janoshik Analytical. Intended for laboratory research use only; not for human consumption, diagnosis, or treatment. View transparency report Compliance PDFs
Documentation & standards
- How to Read a Peptide Certificate of Analysis (COA)
- Peptide Storage and Handling: Temperature, Light and Stability
- Research-Use-Only Compliance: What the Label Obligates
Advanced metabolic research compound. Studied in metabolic and energy pathway models. High-purity research-grade material.
Mix and match any items — discount applies automatically at checkout.
Reminder email when it's time to reorder. No card on file. Cancel anytime from your account — or email support@aresresearchlab.com.
Research selection for metabolic and bioenergetic pathway research.
Build the full stack →Batch transparency
- Batch / lot
- Released with your order
- Testing lab
- Janoshik Analytical
- Purity (HPLC)
- ≥99% target spec
- Identity (MS)
- Available on request
- Report issued
- Available on request
- Full PDF report
- By request
Every request returns a reference number and a live status page. See all published batch records →
For laboratory research use only — not for human or veterinary use.
Earn 49 loyalty points on this purchase · 100 pts = $5 off
Create a Research Account to unlock full batch data, COAs, and priority releases.
Intended strictly for research and laboratory use only. Not for human consumption.
GLP-3RT — Elite Multi-Pathway Research Compound
GLP-3RT represents the highest tier in the Ares metabolic research line. Designed for elite-level research applications, this compound is studied in multi-pathway metabolic and energy regulation systems.
GLP-3RT is formulated for researchers seeking maximum depth in pathway interaction and advanced metabolic modeling.
Third-party purity testing available upon request.
Key Features
- Elite-tier research compound
- Multi-pathway research focus
- Premium batch purity
- Advanced formulation standards
GLP-3RT Research Applications
- Complex metabolic research models
- Multi-pathway signaling studies
- Advanced energy regulation systems
Research Classification
Storage Information
GLP-3RT Purity & COA Verification
For laboratory research use only. Not for human consumption, diagnosis, or treatment.
GLP-3RT — Compound Information & Scientific Literature
Reference data for laboratory personnel: molecular identity, storage and stability handling, our analytical testing panel, and peer-reviewed literature indexed on PubMed.
Molecular Profile
| Compound | GLP-3RT |
|---|---|
| Molecule type | Metabolic Research Compound |
| Class | Metabolic Research Compound |
| Catalog category | Metabolic & Fat Loss Research |
| Physical format | Lyophilized vial |
Handling Reference
-20 °C, protected from light and moisture
24 months from date of manufacture in the sealed vial
2-8 °C (refrigerated), do not freeze after reconstitution
Stability studied out to approximately 28 days under continuous refrigeration
Analytical Testing Panel
Verified by Janoshik Analytical — full panel, every batch. Second independent lab confirmation is being added batch by batch.
Quantifies the main peak against related-substance peaks, so the stated purity percentage is measured rather than assumed.
Every GLP-3RT lot passes all 8 stages before it is released. Expand a stage to see the method and why we run it.
- Method on the COARP-HPLC (UV 214 nm)Why Ares runs it
Quantifies the main peak against related-substance peaks, so the stated purity percentage is measured rather than assumed.
- Method on the COAQuantitative HPLC mass/concentration assayWhy Ares runs it
Confirms the vial actually contains the labeled amount — purity alone says nothing about how much material is in the vial.
- Method on the COAMass Spectrometry (ESI-MS)Why Ares runs it
Confirms the measured molecular mass matches the declared compound — the check that catches a mislabeled or substituted vial.
- Method on the COAICP-MSWhy Ares runs it
Screens for elemental contaminants carried over from synthesis, reagents, or packaging.
- Method on the COAMembrane filtration, USP <71> methodologyWhy Ares runs it
Checks the finished lyophilized vial for microbial growth after fill and closure.
- Method on the COALAL assay (kinetic chromogenic)Why Ares runs it
Measures bacterial endotoxin load, a contamination marker that purity testing alone will not reveal.
- Method on the COAIndependent batch review against release specificationWhy Ares runs it
Ties the analytical numbers back to the paperwork — the lot you receive is the lot on the certificate.
- Method on the COALC-MS/MS targeted screenWhy Ares runs it
A contamination check most research suppliers never run, and the reason we run it on every batch regardless of compound.
PASS reflects the batch release standard every lot must meet before it ships. Per-lot results are published on that lot's Certificate of Analysis.
Peer-Reviewed References
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
Coskun T et al. · Cell metabolism, 2022 · PMID 35985340
View sourceLY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Urva S et al. · Lancet (London, England), 2022 · PMID 36354040
View sourceGlucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
Kopp KO et al. · Pharmacological research, 2022 · PMID 36372278
View sourceEfficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
Bajaj HS et al. · Lancet (London, England), 2026 · PMID 42250575
View sourceIncretins (GLP-1 receptor agonists and dual/triple agonists) and the liver
Newsome PN et al. · Journal of hepatology, 2023 · PMID 37562748
View source
References are listed for literature-identification purposes only. Ares Research is not affiliated with the authors, journals, or institutions cited.
This material is supplied for laboratory and research use only. It is not for human or veterinary use, and it is not a drug, food, or cosmetic. These statements have not been evaluated by the Food and Drug Administration. No information on this page is intended to diagnose, treat, cure, or prevent any condition.
GLP-3RT research questions
+What purity standard applies to GLP-3RT?
GLP-3RT (research retatrutide analog) is manufactured to ≥99% purity, validated by HPLC and mass spectrometry with a public batch COA.
+How does GLP-3RT differ from semaglutide and tirzepatide in receptor pharmacology?
GLP-3RT is a triple agonist studied at GLP-1, GIP, and glucagon receptors, while semaglutide is a GLP-1 mono-agonist and tirzepatide is a GLP-1/GIP dual agonist. See /compare/retatrutide-vs-tirzepatide and /compare/retatrutide-vs-semaglutide.
+How is GLP-3RT reconstituted for research?
Add bacteriostatic water slowly against the vial wall and swirl gently until fully dissolved. Use /tools/reconstitution-calculator to compute per-dose volume for your target concentration.
+Is GLP-3RT approved for human use?
No. GLP-3RT is a research analog supplied for in vitro and preclinical laboratory use only.
Read the GLP-3RT research
Research-only pharmacokinetic profile of Semaglutide: serum half-life, Tmax, route comparisons, clearance and bioavailability — curated from published preclinical and clinical PK literature.
Read article →Research-only pharmacokinetic profile of Tirzepatide: serum half-life, Tmax, route comparisons, clearance and bioavailability — curated from published preclinical and clinical PK literature.
Read article →Tirzepatide vs cagrilintide compared: dual GIP/GLP-1 incretin vs long-acting amylin analog, mechanism, dosing and stacking research.
Read article →AOD-9604 vs semaglutide for body-composition research: lipolysis-targeted GH fragment vs GLP-1 receptor agonist.
Read article →Semaglutide is a long-acting GLP-1 receptor agonist — a fatty acid–conjugated glucagon-like peptide-1 analogue with a one-week plasma half-life — approved as Ozempic (diabetes) and Wegovy (obesity), and now the subject of the most comprehensive cardiometabolic and emerging neurological research programme of any peptide-class compound in modern pharmacology.
Read article →Tirzepatide is the world's first dual GIP/GLP-1 receptor co-agonist — a 39-amino acid synthetic peptide (Mounjaro; Zepbound) achieving unprecedented weight loss of up to 22.5% in clinical trials, and redefining the ceiling of pharmacological obesity treatment through simultaneous activation of two complementary incretin hormone pathways.
Read article →How Ares compares for GLP-3RT
Independent, documentation-first breakdowns of the vendors researchers most often ask about for this compound. COA verification, US shipping, and sourcing transparency, side by side.
Frequently bought together
Curated complements for this compound — researchers most often pair it with these.
Research Use Disclaimer
Researcher Reviews
Sign in with the account that placed your order to leave a verified review.
Ask the Lab
No public questions yet — be the first to ask.
All testing documentation and COA data are provided for laboratory research use only and are not intended to support human consumption, diagnostic, or therapeutic use.
Independent Certificate of Analysis
Independently tested by Ares Research Analytical Lab. Verified and batch-tracked by Ares Research. Additional reports available upon request.
No fillers. No shortcuts. Only verified compounds.
